Caisse De Depot Et Placement Du Quebec Sarepta Therapeutics, Inc. Transaction History

Caisse De Depot Et Placement Du Quebec

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $2.06 Million - $2.9 Million	-32,800 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $618,870 - $886,116	-9,800 Reduced 23.0%	32,800 $2.56 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $3.29 Million - $4.24 Million	42,600 New	42,600 $3.84 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $89,734 - $209,835	-1,242 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $95,174 - $135,484	-758 Reduced 37.9%	1,242 $212,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $12,712 - $17,234	-100 Reduced 4.76%	2,000 $281,000
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $195,300 - $360,570	2,100 New	2,100 $337,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.